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AbstrAct
background Evidence on sex differences in physical 
morbidity in childhood and adolescence is based largely on 
studies employing single/few physical morbidity measures 
and different informants. We describe sex differences in 
a wide range of parent/carer-reported physical morbidity 
measures between ages 4 and 13 years to determine 
evidence for a generalised pattern of an emerging/
increasing female ‘excess’.
Methods Parents/carers (approximately 90% mothers) 
of the population-based UK ALSPAC cohort provided data 
on general health, physical conditions/symptoms and 
infections in their child approximately annually between 
ages 4 and 13. Logistic regression analyses determined 
the odds of each morbidity measure being reported in 
respect of females (vs males) at each age and the sex-by-
age interaction, to investigate any changing sex difference 
with age.
results Six measures (general health past year/
month, high temperature, rash, eye and ear infections) 
demonstrated an emerging female ‘excess’, and six 
(earache, stomach-ache, headache, lice/scabies, cold 
sores, urinary infections) an increasing female ‘excess’; 
one (breathlessness) showed a disappearing male ‘excess’. 
Just two showed either an emerging or increasing male 
‘excess’. Most changes were evident during childhood 
(prepuberty). Six measures showed consistent female 
‘excesses’ and four consistent male ‘excesses’. Few 
measures showed no sex differences throughout this 
period of childhood/early adolescence.
conclusion Sex differences are evident for a wide 
range of parent-reported physical morbidity measures 
in childhood and early adolescence. Far more measures 
showed an emerging/increasing female ‘excess’ than 
an emerging/increasing male ‘excess’. Further studies 
are required to examine whether patterns differ across 
sociodemographic/cultural groups, and to explain this 
generalised pattern.
IntroductIon
An emerging or increasing female ‘excess’ 
in psychological morbidity1 2 over the tran-
sition to adolescence is well recognised. 
Evidence of an emerging/increasing female 
‘excess’ in several measures of common 
physical morbidity is less well established.3–5 
Furthermore, since most epidemiological 
studies focus on single, or small groups of 
conditions, the degree to which this might 
reflect a generalised pattern in sex differences 
in physical morbidity has rarely been inves-
tigated.
A previous systematic review and meta-anal-
ysis, based on a range of self-reported/
routinely collected physical morbidity 
measures in Western children and adoles-
cents, examined whether higher prevalence 
among males in childhood is replaced by 
higher prevalence among females in adoles-
cence.5 It found an emerging/increasing 
female ‘excess’ with increasing age for self-re-
ported general health and several specific 
symptoms. This pattern was strongest for 
headache, abdominal pain and tiredness and 
weaker for back pain and dizziness. It was 
also evident for self-reported migraine, but 
not two conditions based on routinely collected 
data, epilepsy (no sex differences) and type 
1 diabetes (weak emerging/increasing male 
‘excess’). The age when a female ‘excess’ was 
first evident varied by morbidity measure; 
around 6–8 years for self-assessed health, 
abdominal pain, dizziness and headache 
(earlier than expected given previous liter-
ature associating female puberty with these 
What this study adds?
 ► We observed a predominant pattern of an 
emerging/increasing female ‘excess’ in a broad 
range of physical morbidity measures between 
ages 4 and 13 years (rather than no sex differences 
or an emerging/increasing male ‘excess’).
 ► Further studies are required to corroborate and 
explain these findings and understand long-term 
implications for sex differences in adult health.
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Original article
What is already known on this topic?
 ► Evidence of an emerging/increasing female 
‘excess’ in physical morbidity over the transition 
to adolescence is less well established than that in 
respect of psychological morbidity.
 ► Most studies of sex differences in child/adolescent 
physical morbidity focus on single/few conditions, 
so cannot investigate the degree to which results 
reflect a generalised pattern.
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physical symptoms6–8), and around 9–11 years for back 
pain, sleeping problems/tiredness and migraine.
More robust evidence for an emerging/increasing 
female ‘excess’ in self-report than routinely collected 
data5 suggests the need for careful consideration of 
the impact of data source in studies/reviews focusing 
on morbidity measured over the transition to adoles-
cence. Changing sex differences with age may reflect 
underlying biological changes, or societal expectations, 
of which conditions, symptoms or infections are more 
‘appropriate’ for either males or females at different life 
stages. Apparent sex-by-age differences in morbidity may 
therefore partly reflect whether data are self-reported 
(impossible at younger ages), proxy-reported (requiring 
awareness of symptoms by another, with or without them 
having been specifically informed by the sufferer) or 
routinely collected (requiring awareness of symptoms by 
the sufferer or another, followed by presentation to, and 
diagnosis by, health professionals).
Further evidence from other reviews broadly suggests 
an emerging female ‘excess’ occurring around puberty 
in several measures of common physical morbidity, 
including asthma,9–12 eczema12 13 and respiratory infec-
tions,14 a consistent female excess in both urinary tract 
infections15 16 and musculoskeletal pain,17 and no clear 
sex-by-age pattern in food allergy.12 However, many such 
reviews do not consider the issue of data source,9 10 14 15 17 
and while others refer to different methods/condition 
presentations, potential impacts on results are not consid-
ered systematically11 16 or at all.12 13 Similarly, some studies 
of sex-by-age differences in common childhood/adoles-
cent conditions are unclear about data source,18 or 
based on parental report at younger ages and self-report 
thereafter, but without acknowledging this might have 
impacted on results.19 20
This paper presents analysis of sex differences in a wide 
range of parent/carer-reported (almost all mother-reported) 
physical morbidity measures (general health; conditions 
and symptoms; infections) between ages of 4 and 13 in a 
large UK birth cohort. This allows exploration of:
1. Whether there is evidence of an emerging/increasing 
female ‘excess’ across these measures, reflecting a 
generalised pattern;
2. When any emerging female ‘excess’ occurs;
3. Whether the sex-by-age patterns seen in the more 
restricted set of child/adolescent self-reported physical 
morbidity measures and described in a previous 
systematic review5 are replicated in parent-reported 
measures.
Method
Participants
Data are from the Avon Longitudinal Study of Parents 
and Children (ALSPAC),21 22 a population-based cohort 
study in South-West England. Pregnant women with esti-
mated delivery date 1 April 1991 to 31 December 1992, 
were invited to participate, resulting in a cohort of 14 541 
pregnancies, with 13 988 singletons and first-born twins 
alive at 1 year.
ALSPAC’s study website includes details of available 
data via a fully searchable data dictionary (www. bristol. 
ac. uk/ alspac/ researchers/ access/). All data for this anal-
ysis were from ‘child-based’ questionnaires, completed by 
their main carer at roughly 1 year intervals, from approx-
imately age 4 (57 months; n=4967 male and 5252 female 
questionnaires; 90% (n=9234) completed by mothers) 
to 13 years (166 months; n=3682 male and 3678 female 
questionnaires; 93% (n=6809) completed by mothers).
Measures
Table 1 details the 32 morbidity measures analysed 
here and the child ages when they were included. 
Included measures comprised: three general health 
(health in past month and year, and health-related 
school absences); 19 conditions and symptoms (diar-
rhoea, vomiting, cough, high temperature, earache, 
ear discharge, stomach-ache, rash, wheezing, breath-
lessness, headache, constipation, lice/scabies, eczema, 
asthma, hay fever, pains in arms/legs, food/drink aller-
gies, other allergies) and 10 infections (chicken pox, 
cold sores, eye infection, ear infection, chest infection, 
tonsillitis/laryngitis, influenza, cold, urinary infection, 
worm infections).
Analyses
For each morbidity measure, age-specific logistic regres-
sion analyses determined the odds of it being reported 
in respect of females (vs males). Sex-by-age interactions 
(testing for a changing sex difference with age) were then 
included in further logistic regression analyses, based on 
reports at all ages, with robust SEs to allow for non-inde-
pendence of observations from the same child.
Results are presented as graphs for each measure, 
showing female versus male ORs at each age. The graphs 
have logarithmic scaling (eg, ORs of 2 (females twice 
as likely) and 0.5 (females half as likely) are the same 
distance from 1 (no sex difference)). The graphs are 
presented in three sections (general health; conditions 
and symptoms; infections) and, within these, according 
to potential patterns of sex-by-age differences, which a 
previous systematic review conceptualised in terms of 
four ‘types’,5 and are defined here as:
 ► ‘Type 1’: an emerging/increasing female ‘excess’, 
or disappearing male excess with age, occurring 
because female rates increase more than those of 
males or decrease less than those of males, resulting 
in a marked sex-by-age interaction. Type 1 patterns 
therefore include: (a) a male ‘excess’ reversing to a 
female ‘excess’, or no sex difference at younger ages, 
but a female ‘excess’ at older ages (emerging female 
‘excess’); (b) a female ‘excess’ at younger ages, in-
creasing with age (increasing female ‘excess’) or (c) a 
male ‘excess’ at younger ages, but no sex difference at 
older ages (disappearing male ‘excess’). For ‘type 1’ 
patterns, the odds of morbidity among females com-
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Table 1 Morbidity measures and ages collected
Measure
How coded for analysis/
additional notes
Age in months
57 65 69 81 91 103 128 140 157 166
General health
  How would you 
assess the health of 
your child in the past 
month? In the past 
year?
‘Sometimes quite ill’ or ‘almost 
always unwell’ (categorised 
here together as ‘poor’) vs ‘very 
healthy, no problems’ or ‘healthy, 
but a few minor problems’
X X X X X X X X X
  How many days the 
child had taken off 
school in the past 
year.
For a range of health reasons 
(infections, asthma/eczema/
hay fever, hospital or other 
investigations/admissions, other 
reasons). Any days off for any 
health reason vs none
X X X X X
Conditions and symptoms
  Has child had any of 
the following?
Since age 3 (at 57 months); in the 
past 15 months (at 69 months); in 
the past year (all other ages)
  Diarrhoea X X X X X X X X
  Vomiting X X X X X X X X
  Cough X X X X X X X X
  High temperature X X X X X X X X
  Earache X X X X X X X X
  Ear discharge (pus) X X X X X X X X
  Stomach-ache(s) X X X X X X X X
  Rash X X X X X X X X
  Wheezing X X X X X X X X
  Breathlessness X X X X X X X X
  Headache(s) X X X X X X X X
  Constipation X X X X X X X X
  Lice or scabies Asked separately from 81 months; 
combined for consistency in 
analyses
X X X X X X X X
  Eczema X X X X X X
  Asthma X X X X X X
  Hay fever X X X X X X
  Child often has pains 
in arms or legs
X X X X X X
  Are there any foods 
or drinks that your 
child is allergic to?
X X X X
  Apart from food and 
drink are there any 
other things to which 
child is allergic?
X X X X
  Snuffles/cold* X X X X X
  Urinary infection† X X X X X
  Blood in stools‡ X X X X X X X X
  Convulsions/fits‡ X X X X X X X X
  Episodes of stopping 
breathing‡
X X X X X X X X
Continued
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Measure
How coded for analysis/
additional notes
Age in months
57 65 69 81 91 103 128 140 157 166
  Convulsion, fit 
or seizure due to 
epilepsy‡
X X X X X
  Accident§ X X X X X X X X
Infections
  Has child had any 
of the following 
infections?
Since age 3 (at 57 months); in the 
past 15 months (at 69 months); in 
the past year (all other ages)
  Chicken pox X X X X X X X
  Cold sores X X X X X X X
  Eye infection X X X X X X X
  Ear infection X X X X X X X
  Chest infection X X X X X X X
  Tonsilitis/laryngitis X X X X
  Influenza X X X X
  Cold* X X X X
  Urinary infection† X X X X X X X
  Worm infections¶ X X X X X X X X
  Measles‡ X X X X X X X
  Mumps‡ X X X X X X X
  Meningitis‡ X X X X X X X
  Whooping cough‡ X X X X X X X
  German measles‡ X X X X
  Scarlet fever‡ X X X X
  Glandular fever** X
*Reported by parent as ‘cold/snuffles’ (within conditions list) at 57, 69, 81, 91 and 103 months and ‘cold’ (within infections list) at 128, 157 and 
166 months were combined and included here as ‘cold’ (categorised under infections).
†Reported by parent within both conditions (57–103 months) and infections (57–166 months) lists, so only results in respect of infections data 
included here.
‡Excluded from analyses as reported in respect of very small numbers (fewer than 20 males and/or females).
§Excluded from analyses as out with the scope of the paper.
¶Reported by parent within conditions list, but included here within infections.
**Excluded from analysis as only one time point.
Table 1 Continued 
pared with males start below, at, or above unity and 
increase with age.
 ► ‘Type 2’: (a) stable female ‘excess’; (b) stable lack of 
a sex difference or (c) stable male ‘excess’. For ‘type 
2’ patterns, the odds of female versus male morbidity 
are consistently either above, below or at unity.
 ► ‘Type 3’: variations on an emerging/increasing male 
‘excess’, or disappearing female ‘excess’ (the reverse 
of ‘type 1’). For ‘type 3’ patterns, the odds of female 
versus male morbidity start above, at or below unity 
and decrease with age.
 ► ‘Type 4’: mixed/unclassifiable patterns.
(Note precise definitions are included as footnotes to 
the results graphs.)
Results are based on cross-sectional samples at each 
age. Two sets of sensitivity analyses were completed. One 
was restricted to a longitudinal subsample, selecting 
only those for whom data were available at all relevant 
ages, n=4454. The other was conducted for the ‘moth-
er-only’ subsample, selecting only mother-completed 
data, to investigate whether completion by different 
carers at different ages might impact on the results. 
Online supplementary table 1 shows cross-sectional, 
longitudinal and mother-only sample sizes. Online 
supplementary table 2 shows the characteristics of those 
included/not included in the samples and demon-
strates that due to sample attrition, those included were 
more likely to be first-born children of mothers in a 
first marriage, of higher socioeconomic status, and who 
had never smoked. Results from both the longitudinal 
and mother-only samples were almost identical to the 
cross-sectional results. Online supplementary tables 
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Figure 1 General health measures (with P values for significance of sex-by-age interactions).
3–5 show results based on each sample. Finally, given 
that some have suggested Poisson as an alternative to 
logistic regression for analysis of cross-sectional studies 
with binary outcomes,23 we also conducted Poisson 
regression analyses on the cross-sectional samples. 
Results (expressed as risk ratios, rather than ORs) were 
very similar to those obtained via logistic regression 
(see online supplementary tables 6–8).
results
General health
Figure 1 shows a ‘type 1a’ female ‘excess’ emerging by 
128 months for parent-reported poor general health in 
their child over the last month (OR=1.02, 95% CI 0.76 
to 1.36 at 57 months; OR=1.97, 95% CI 1.26 to 3.10 at 
166 months; sex-by-age interaction P=0.01) and the 
last year (OR=0.85, 95% CI 0.66 to 1.08 at 57 months; 
OR=1.50, 95% CI 1.07 to 2.11 at 166 months; interaction 
P<0.001). Days off school in the last year was unavail-
able at the youngest ages, but showed a small consistent 
female ‘excess’ (‘type 2a’ pattern) from 91 to 166 months 
(OR=1.15, 95% CI 1.04 to 1.28 at 91 months; OR=1.18, 
95% CI 1.05 to 1.33 at 166 months; interaction P=0.68).
conditions and symptoms
Figure 2 shows that for 6 of the 20 conditions/symptoms 
measures, there was an emerging/increasing female 
‘excess’, while one showed a disappearing male ‘excess’ 
(all ‘type 1’ patterns). Thus, although there were no sex 
differences at younger ages, a female ‘excess’ emerged 
in respect of rates of parent-reported high temperature 
by 128 months and, more markedly, rash by 81 months 
(interaction P=0.01 and <0.001, respectively). Earache, 
stomach-ache, headache and head lice/scabies were more 
likely to be reported in respect of females at younger ages, 
but this female ‘excess’ increased with age (interaction 
P<0.001). Reported breathlessness also showed a type 1 
sex-by-age interaction, from a male ‘excess’ at younger 
ages which disappeared, resulting in no sex difference at 
older ages (OR=0.63, 95% CI 0.54 to 0.73 at 57 months; 
OR=1.05, 95% CI 0.87 to 1.26 at 166 months; interaction 
P<0.001).
Ten conditions/symptoms showed stable (‘type 2’) sex 
differences/lack of sex differences with age. Thus, two 
(constipation and eczema) showed a female ‘excess’ 
at almost all ages and three a consistent male ‘excess’ 
(wheezing, asthma and hay fever). A further five were 
largely consistent in showing no marked sex difference at 
any age (cough, vomiting, ear discharge, food and other 
allergy).
Finally, two conditions/symptoms (pain in arms/legs 
and diarrhoea) showed an emerging/increasing male 
‘excess’ (‘type 3’ patterns). There was no sex difference 
in respect of pain in arms/legs at younger ages (OR=0.95, 
95% CI 0.85 to 1.07 at 57 months), but a small male 
‘excess’ emerged by 140 months and was maintained at 
157 months (OR=0.81, 95% CI 0.74 to 0.90 at 157 months; 
interaction P=0.001). Diarrhoea showed an increasing 
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Figure 2 Conditions/symptoms measures (with P values for significance of sex-by-age interactions).
male ‘excess’, being more likely to be reported in males 
at all ages, particularly older ages (OR=0.89, 95% CI 0.82 
to 0.96 at 57 months; OR=0.77, 95% CI  0.69 to 0.85 at 
166 months; interaction P=0.004).
Infections
Figure 3 shows an emerging/increasing female ‘excess’ in 
4 of the 11 parent-reported infections (‘type 1’ patterns), a 
consistent female ‘excess’ in 3, a consistent male ‘excess’ in 
1 and no sex difference in 2 (‘type 2’ patterns).
Among infections showing an emerging/increasing 
female ‘excess’, there were no sex differences in parent-re-
ported child eye and ear infections at younger ages, but a 
female ‘excess’ emerged for eye infections by 103 months 
and ear infections by 81 months (interaction P<0.001 for 
both). Parent-reported cold sores and, more markedly, 
urinary infections (note different scale on graph) were 
higher in females0 at all ages, but this sex difference 
increased with age (eg, for urinary infections, OR=2.35, 
95% CI 1.97 to 2.81 at 57 months; OR=5.13, 95% CI 3.30 
to 7.98 at 166 months; interaction P<0.001). Finally, among 
the infections showing ‘type 2’ patterns, there was a consis-
tent female ‘excess’ in respect of reported tonsillitis, cold/
snuffles and worm infections, no sex difference in chicken 
pox and influenza and a consistent male ‘excess’ in respect 
of chest infections.
dIscussIon
This is the first study to examine sex differences in a range 
of parent-reported physical morbidity measures during 
childhood and adolescence and explore age-based 
changes.(Table 2)
Given evidence of a generalised pattern for psycholog-
ical morbidity measures, we were interested in whether 
there was also a generalised pattern of an emerging/
increasing female ‘excess’ across these physical morbidity 
measures and, if so, when this occurred. As summarised 
in table 2, of the 32 measures examined, only 7 showed 
no sex differences throughout the included age ranges. Six 
were categorised as showing an emerging female ‘excess’, six 
an increasing female ‘excess’ one a disappearing male ‘excess’ 
(‘type 1’ patterns) and six a consistent female ‘excess’. In 
contrast, only one showed an emerging male ‘excess’, one 
an increasing male ‘excess’ (‘type 3’ patterns) and four a 
consistent male ‘excess’. Thus, far more measures showed an 
emerging/increasing female ‘excess’ than an emerging/
increasing male ‘excess’ or no sex difference.
We also wished to know whether sex-by-age patterns in 
a more restricted set of child/adolescent self-reported phys-
ical morbidity measures described in a previous review,5 
were replicated when these measures were parent-reported, 
as here. Three measures (general health, headache, 
abdominal pain) are included in both studies. The review 
found a marked female ‘excess’ in each, based on self-re-
ports, from around 6–8 years. The current analysis, based 
on parent-reported measures, had broadly similar find-
ings, but suggested an even earlier small female ‘excess’ 
in headache and stomach-ache.
How can these complex patterns of sex differences 
in parent-reported morbidity be explained? Female 
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Figure 3 Infections measures (with P values for significance of sex-by-age interactions).
puberty is associated with physical symptoms, including 
menstrual cramps and headaches.6–8 Although previous 
literature suggests higher male rates of asthma, eczema, 
respiratory infections and perhaps hay fever at younger 
ages, reversing around puberty,9–14 18 19 we observed a 
consistent male ‘excess’ in asthma, wheeze, hay fever 
and chest infections throughout the age range consid-
ered here. It is possible that a ‘reversal’ occurred later in 
puberty in the ALSPAC cohort. However, the consistently 
higher female eczema rates cannot be explained in this 
way. While potential explanations might be constructed 
for some findings (eg, the increasing female ‘excess’ in 
lice/scabies throughout childhood might result from 
girls’ often longer hair and/or greater time spent in 
physically close social interactions24), others, such as an 
emerging/increasing female ‘excesses’ in temperature, 
rash, earache/infection, eye infection or cold sores are 
harder to explain.
Another potential explanation is that some of these sex 
differences in parent-reported morbidity measures result 
from different illness-related attitudes/expectations (by 
both children and parents) in respect of males compared 
with females. Parental expectations about, and rein-
forcement of, their child’s emotional expressivity differ 
according to child sex,25 as do ratings of, and responses 
to, paediatric pain.26 27 Perhaps these translate into differ-
ences in acknowledging, recalling and reporting illness 
in respect of boys and girls. There are few studies in this 
area and stereotyped attitudes and expectations relating 
to sex differences may differ according to what aspect of 
child morbidity is being considered.
The strengths of this study include its large sample size 
and wide range of morbidity measures, enabling us to 
address previously unexplored questions. Analyses based 
on cross-sectional samples produced almost identical 
results to those limited to the longitudinal sample (which 
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Table 2 Summary of patterns of sex-by-age differences in each morbidity measure
General health Conditions and symptoms Infections
‘Type 1’
  1a: Emerging female excess General health – Past year
General health – Past month
High temperature
Rash
Eye infection
Ear infection
  1b: Increasing female excess Earache
Stomach-ache
Headache
Lice/scabies
Cold sores
Urinary infection
  1c: Disappearing male excess Breathlessness
‘Type 2’
  2a: Consistent female excess Health-related days off school Constipation
Eczema
Tonsillitis/laryngitis
Cold
Worm infections
  2b: Consistent no sex difference Vomiting
Cough
Ear discharge
Food/drink allergies
Non-food/drink allergies
Chicken pox
Influenza
  2c: Consistent male excess Wheezing
Asthma
Hay fever
Chest infection
‘Type 3’
  3a: Emerging male excess Pain in arms/legs
  3b: Increasing male excess Diarrhoea
was subject to differential attrition) and mother-only 
samples (which eliminated different carers reporting on 
a child’s health at different ages). Findings such as the 
much higher rates of urinary infections among females 
at all ages and markedly increasing female ‘excess’ in 
stomach and headaches in early adolescence, are consis-
tent with other research.6–8 15 16 However, we also draw 
attention to potential limitations. Our categorisation of 
patterns of sex-by-age differences in physical morbidity, 
based on graphs and interactions, could be regarded as 
simple, and the fact that we conducted analyses on 32 
morbidity measures introduces the possibility of spurious 
(chance) significance for some sex-by-age interactions due 
to multiple testing. However, our focus was on consistent 
patterns of ORs with age and these are unlikely to have 
arisen purely by chance. In addition, there is no reason to 
think that spurious interactions would occur more often 
for measures showing a ‘type 1’ pattern. Another limita-
tion is that this secondary analysis of existing data from 
a well-established cohort was inevitably limited by the 
specific measures chosen by the ALSPAC team at each 
age. In particular, lack of comparable data at older ages 
prevents extension of the analysis to mid-later adoles-
cence. Furthermore, although there was little evidence 
of differential attrition according to child sex, the sample 
was more advantaged than the general population, thus 
potentially limiting generalisability of the findings.
Based on rigorous analysis questioning, we believe 
for the first time, whether age-based changes in sex 
differences in child and adolescent physical morbidity 
follow specific patterns (as proposed in a prior review5), 
this analysis suggests both substantive and methodolog-
ical conclusions. Substantively, it is intriguing that sex 
differences are evident in respect of a wide range of 
parent-reported physical morbidity measures in child-
hood and early adolescence, generally indicating poorer 
health in girls. While some measures show consistent 
female or male ‘excesses’, many show an emerging/
increasing female ‘excess’ in childhood, consistent with 
findings for psychological morbidity,1 2 which are evident 
prepuberty; almost none shows an emerging/increasing 
male ‘excess’. This pattern of ‘excess’ female morbidity 
by/before puberty highlights important inequities, with 
public health implications, not least in future health 
service usage. Many of these (changing) sex differences 
are hard to explain on the basis of existing literature, 
suggesting, as in adults,28 the need for further quantita-
tive studies to corroborate these findings and to examine 
whether patterns differ across sociodemographic or 
cultural groups. There is also a need for further qualita-
tive or experimental studies to examine the social and/
or biological mechanisms underlying these findings.29 30 
Methodologically, possible differences according to data 
source (routine data, child/proxy-reported) highlight 
the need for reviews of sex-by-age differences in child/
adolescent morbidity to pay close attention to this issue 
and for studies which systematically compare results 
based on multiple sources.
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